🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to assess the efficacy of Buscopan® (hyoscine butyl...
Status
Completed
Location
202.848.86016 Boehringer Ingelheim Investigational Site
Start Date
2013-08
Trial ID
NCT01929044
Treatments Being Tested
Postoperative nausea and vomiting (PONV) is particularly one of the most co...
Status
Unknown
Location
The Second Hospital of Anhui Medical University
Start Date
2022-09-23
Trial ID
NCT05375721
Treatments Being Tested
Anisodamine has been widely used in China for its pharmacological effect on...
Status
Completed
Location
Huizhou first hospital
Start Date
2015-04
Trial ID
NCT02442440
Treatments Being Tested
This study aims to determine the role of Glycopyrrolate in preventing posto...
Status
Completed
Location
The Second Affiliated Hospital Of Chongqing Medical University
Start Date
2023-10-01
Trial ID
NCT06045364
Treatments Being Tested
Postoperative nausea and vomiting (PONV) is particularly distressing althou...
Status
Completed
Location
Second Affiliated Hospital of Anhui Medical University
Start Date
2022-02-20
Trial ID
NCT05240482
Treatments Being Tested
The study aimed to investigate the effectiveness of anisodamine hydrobromid...
Status
Recruiting
Location
Beijing Chaoyang Hospital, Capital Medical University
Start Date
2024-01-25
Trial ID
NCT05634057
Treatments Being Tested
This prospective, randomized, controlled clinical study aims to evaluate th...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2022-07-29
Trial ID
NCT05727163
This prospective, multicenter, single-arm, open-label interventional pilot ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
Start Date
2026-08-01
Trial ID
NCT07657702
Treatments Being Tested